Numerous studies indicate that PDE inhibitors present a wide range of pharmacological activities, including anti-inflammatory, anti-oxidant, vasodilator, anti-cancer, and neuroprotective properties, suggesting that they can be used as potential drugs for the treatment of respiratory tract diseases, cardiovascular system diseases, depression, dementia, and PD.44–47. This evidence concerns the gene ALDH7A1 and major depressive disorder.